New ISOPP E-Learning: Understanding SACT and Cytotoxic Risks

Systemic Anti-Cancer Therapy (SACT) and other cytotoxic drugs are critical in cancer treatment but pose serious occupational and environmental risks if not handled properly. Healthcare systems in Low- and Middle-Income Countries (LMICs) often lack the infrastructure, resources, and training necessary to mitigate these risks.

This course is designed to provide healthcare professionals with essential knowledge and practical guidance for the safe handling, storage, administration, and disposal of systemic anti-cancer therapy (SACT) and cytotoxic agents, in order to protect patients, staff, and the environment from harmful exposure.

Access to the program is complimentary for ISOPP members.

Learn More

Related News

ISOPP News

Your bispecific antibody questions, answered by our expert pharmacists. HOPA is proud to introduce the new Pharmacy Peer Network, which provides timely, one-on-one access to subject matter experts who can help individuals navigate questions and challenges related to bispecific therapies with confidence.

ISOPP News

Understanding Targeted Therapies and Immunotherapies for Cancer ISOPP's Understanding Targeted Therapies and Immunotherapies for Cancer (UTIC) course - developed in collaboration with the British Oncology Pharmacy Association - is currently available on our e-learning platform.

ISOPP News

New 2026-2027 Secretariat (Incoming) Congratulations!